Showing results (81-90 of 123) with videos related to
Sort By:
Pageof 13
Annals of Surgery|September 6, 2000
Side-to-side isoperistaltic strictureplasty in extensive Crohn's disease: a prospective longitudinal studyF Michelassi, R D Hurst, M Melis, et al.Expert Opinion on Pharmacotherapy|May 5, 2001
Treatment of anal fissures with topical nitroglycerinE D Ehrenpreis, D T Rubin, P M Ginsburg, et al.Alimentary Pharmacology & Therapeutics|September 1, 2005
Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurineM P Sparrow, S A Hande, S Friedman, et al.Gastroenterology|May 1, 1993
Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Pentasa Crohn's Disease Study GroupJ W Singleton, S B Hanauer, G L Gitnick, et al.Alimentary Pharmacology & Therapeutics|June 5, 2013
Randomised clinical trial: the safety and tolerability of Trichuris suis ova in patients with Crohn's diseaseW J Sandborn, D E Elliott, J Weinstock, et al.Alimentary Pharmacology & Therapeutics|June 8, 2011
Adalimumab sustains steroid-free remission after 3 years of therapy for Crohn's diseaseM A Kamm, S B Hanauer, R Panaccione, et al.Inflammatory Bowel Diseases|June 1, 2001
Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot studyB E Sands, W J Tremaine, W J Sandborn, et al.Alimentary Pharmacology & Therapeutics|November 19, 2013
Randomised clinical trial: individualised vs. weight-based dosing of azathioprine in Crohn's diseaseT Dassopoulos, M C Dubinsky, J L Bentsen, et al.Alimentary Pharmacology & Therapeutics|October 24, 2008
Systematic review: impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flaresP D R Higgins, D T Rubin, K Kaulback, et al.Gastroenterology|August 28, 1998
Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: a dose-ranging study. U.S. Budesonide enema study groupS B Hanauer, M Robinson, R Pruitt, et al.Pageof 13